Letter: Coagulopathy with Cefazolin in Uremia
Overview
Authors
Affiliations
Tuberculosis and pharmacological interactions: A narrative review.
Riccardi N, Canetti D, Rodari P, Besozzi G, Saderi L, Dettori M Curr Res Pharmacol Drug Discov. 2021; 2:100007.
PMID: 34909643 PMC: 8663953. DOI: 10.1016/j.crphar.2020.100007.
Deranged Coagulation Profile Secondary to Cefazolin Use: Case Report.
Ngiam J, Liong T, Tham S, Pramotedham T, Alagha R, Yong J Infect Dis Rep. 2021; 13(1):187-190.
PMID: 33804372 PMC: 7931061. DOI: 10.3390/idr13010021.
Evolution of haemostatic parameters and risk of bleeding during treatment with cefazolin.
Strazzulla A, Chakvetadze C, Picque M, Cassard B, Hernandez F, de Pontfarcy A Eur J Clin Microbiol Infect Dis. 2018; 38(1):177-183.
PMID: 30414092 DOI: 10.1007/s10096-018-3412-6.
Cefazolin Induced Liver Injury and Hypoprothrombinemia.
Gupta A, Singh A, Faridi K, Jain P J Clin Exp Hepatol. 2018; 8(2):213-214.
PMID: 29892188 PMC: 5992318. DOI: 10.1016/j.jceh.2017.12.004.
Angaran D, Dias V, Arom K, Northrup W, KERSTEN T, LINDSAY W Ann Surg. 1984; 199(1):107-11.
PMID: 6691723 PMC: 1353267. DOI: 10.1097/00000658-198401000-00019.